AWC
ABBV icon

Abundance Wealth Counselors’s AbbVie ABBV Stock Holding History

Abundance Wealth Counselors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Sell
15,544
-271
-2% -$60.1K 0.48% 28
2025
Q4 		$3.61M Sell
15,815
-265
-2% -$60.4K 0.61% 25
2025
Q3 		$3.72M Sell
16,080
-348
-2% -$70.9K 0.64% 26
2025
Q2 		$3.05M Sell
16,428
-247
-1% -$45.9K 0.57% 29
2025
Q1 		$3.48M Buy
16,675
+388
+2% +$75.4K 0.73% 23
2024
Q4 		$2.89M Buy
16,287
+172
+1% +$31.6K 0.63% 24
2024
Q3 		$3.18M Sell
16,115
-430
-3% -$80.3K 0.66% 19
2024
Q2 		$2.84M Sell
16,545
-1,285
-7% -$213K 1.31% 13
2024
Q1 		$3.25M Buy
17,830
+162
+0.9% +$27.9K 0.75% 20
2023
Q4 		$2.74M Buy
17,668
+250
+1% +$36.4K 0.71% 22
2023
Q3 		$2.6M Sell
17,418
-350
-2% -$51.4K 0.74% 19
2023
Q2 		$2.39M Sell
17,768
-1,671
-9% -$245K 1.24% 13
2023
Q1 		$3.1M Sell
19,439
-1,369
-7% -$209K 0.78% 16
2022
Q4 		$3.36M Buy
20,808
+910
+5% +$140K 0.92% 16
2022
Q3 		$2.67M Buy
19,898
+383
+2% +$55K 0.76% 17
2022
Q2 		$2.99M Sell
19,515
-531
-3% -$81.1K 0.81% 17
2022
Q1 		$3.25M Buy
20,046
+1,325
+7% +$192K 0.88% 17
2021
Q4 		$2.54M Buy
18,721
+818
+5% +$96.6K 0.65% 18
2021
Q3 		$1.93M Buy
17,903
+448
+3% +$51.2K 1.13% 11
2021
Q2 		$1.97M Buy
17,455
+6,166
+55% +$694K 0.51% 19
2021
Q1 		$1.22M Buy
11,289
+1,433
+15% +$153K 0.3% 28
2020
Q4 		$1.06M Buy
9,856
+1,597
+19% +$153K 0.27% 30
2020
Q3 		$723K Buy
8,259
+1,682
+26% +$158K 0.21% 45
2020
Q2 		$646K Buy
+6,577
New +$579K 0.2% 43

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abundance Wealth Counselors's ABBV Position: Q1 2026 in Review

Abundance Wealth Counselors reduced its AbbVie (ABBV) stake by 1.7% in Q1 2026, selling an estimated $60.1K and leaving 15,544 shares worth $3.38M. The position accounts for 0.48% of the portfolio, ranked #28.

Abundance Wealth Counselors first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.72M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Abundance Wealth Counselors held 15,544 shares of AbbVie worth $3.38M as of Q1 2026.
  • Abundance Wealth Counselors sold 271 AbbVie shares in Q1 2026, an estimated $60.1K.
  • AbbVie made up 0.48% of Abundance Wealth Counselors's portfolio in Q1 2026, its #28 holding.
  • Abundance Wealth Counselors first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
  • Abundance Wealth Counselors's AbbVie position peaked at $3.72M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Abundance Wealth Counselors's 13F filing for Q1 2026, filed 23 Apr 2026.